SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-005212
Filing Date
2021-01-08
Accepted
2021-01-08 16:15:52
Documents
1
Group Members
ARIX BIOSCIENCE HOLDINGS LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d97991dsc13da.htm SC 13D/A 58883
  Complete submission text file 0001193125-21-005212.txt   60513
Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Filed by) CIK: 0001700449 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A

Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90550 | Film No.: 21517641
SIC: 2836 Biological Products, (No Diagnostic Substances)